Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Prevost, V.
Right arrow Articles by Bartsch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prevost, V.
Right arrow Articles by Bartsch, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

research-article

Immunoaffinity purification and gas chromatography—mass spectrometric quantification of 3-alkyladenines in urine: metabolism studies and basal excretion levels in man

V. Prevost, D.E.G. Shuker 1, M.D. Friesen, G. Eberle 2, M.F. Rajewsky 2 and H. Bartsch

International Agency for Research on Cancer, Unit of Environmental Carcinogens and Host Factors 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
2Institute of Cell Biology (Cancer Research), West German Cancer Center Essen, University of Essen Medical School Hufeland-Strasse 55, D-4300 Essen 1, Germany

1To whom correspondence should be addressed

Immunoaffinity gels were prepared by coupling monoclonal antibody (Mab) EM-6–47 to protein A —Sepharose, and were used to make small columns retaining 3-alkyladenines (3-alkAde) of diverse structure. An analytical procedure for determination of 3-methyladenine (3-MeAde), 3-ethyladenine (3-EtAde), 3-(2-hydroxyethyl)adenine (3-HOEtAde) and 3-benzyladenine (3-BzAde) was developed. Deuterated internal standards (d3-3-MeAde, d5-3-EtAde, d4-3-HOEtAde and d7-3-BzAde) were synthesized and added to urine samples prior to immunoaffinity purification. 3-alkAde were separated and quantitated as tert-butyl-dimethylsilyl (TBDMS) derivatives by capillary gas chromatography—low resolution mass spectrometry (GC—MS). Detection limits for 3-MeAde, 3-EtAde and 3-HOEtAde were 0.2 pmol/ml urine and for 3-BzAde, 1 pmol/ml urine. Studies in two volunteers showed that 3-MeAde and 3-HOEtAde were excreted almost quantitatively (>90%) within 24 h, that 3-EtAde was less well excreted (67–74%) and that 3-BzAde was poorly excreted (21–25%). Studies on basal levels of 3-alkAde urinary excretion in three volunteers showed that 3-MeAde was >90% derived from the diet as the preformed product. 3-HOEtAde was present at ~10 nmol/day and was reduced to ~1 nmol/day when the diet was standardized suggesting that it is also dietary in origin. 3-BzAde was not detected in human urine. 3-EtAde was not only excreted at low levels (<1 nmol/day) but was also only very slightly affected by diet. This general and sensitive method will be useful in biomonitoring studies in subjects exposed to alkylating agents of diverse structure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Godschalk, J. Nair, F.J. van Schooten, A. Risch, P. Drings, K. Kayser, H. Dienemann, and H. Bartsch
Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking
Carcinogenesis, December 1, 2002; 23(12): 2081 - 2086.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Carcinogenesis, June 1, 2002; 23(6): 907 - 922.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. S. Hage
Affinity Chromatography: A Review of Clinical Applications
Clin. Chem., May 1, 1999; 45(5): 593 - 615.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.